← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Allucent Government Services (Us) Llc
Cary, NC
$4,142,304
Total funding
5
Grants
Funding over time
peak $3.5M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,142,304 · 5
By mechanism
N01$3,782,581 · 4
N02$359,723 · 1
Investigators at Allucent Government Services (Us) Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Task C1: Phase I Clinical Trial to Evaluate Influenza Therapeutics$3,205,231
N01 · FY2024 · AI
Early Phase Clinical Trial Units (EPCTU)$143,797
N01 · FY2025 · AI
Task A: Early Phase Clinical Trial Units (EPCTU)$139,606
N01 · FY2024 · AI
Early Phase Clinical Trial Units$135,540
N01 · FY2023 · AI
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]$134,440
N02 · FY2024 · DA
Early Phase Clinical Trial Units$131,595
N01 · FY2022 · AI
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]$104,363
N02 · FY2023 · DA
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK] - HEAL$58,400
N02 · FY2025 · DA
DRUG METABOLISM AND PHARMACOKINETICS (DMPK) CONSULTING SUPPORT SERVICES$46,020
N02 · FY2024 · DA
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]$16,500
N02 · FY2022 · DA
This service is a MicroContract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Gene Williams, Ph.D. POP: 07/01/2025 to 06/30/2026. HEAL$8,538
N01 · FY2025 · NS
This service is for Micro Contract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Devin Welty, PH.D.; POP: 07/01/2025 to 06/30/2026.$5,840
N01 · FY2025 · NS
HEAL - This service is for Micro Contract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Devin Welty, PH.D.; POP: 07/01/2025 to 06/30/2026.$4,158
N01 · FY2025 · NS
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development$3,408
N01 · FY2023 · AI
Preclinical Services for Biopharmaceutical Product Development$3,408
N01 · FY2023 · AI
This service is a MicroContract for DMPK Expert services for BPN, HEAL and Biologics. Incumbent is Gene Williams, Ph.D. POP: 07/01/2025 to 06/30/2026.$1,460
N01 · FY2025 · NS